NDC 76045-006-01 - Morphine Sulfate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76045-006
- Requested NDC
- 76045-006-01
- Package NDCs from labels
- 76045-006-01, 76045-006-11, 76045-006-02, 76045-006-12
- Manufacturer
- Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC
- Effective date
- 2026-08-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Morphine Sulfate - Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC | Fresenius Kabi, USA LLC | Fresenius Kabi USA, LLC | 2026-08-31 | HUMAN PRESCRIPTION DRUG LABEL |
| Morphine Sulfate - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2025-09-04 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76045-006-01 | Morphine Sulfate | 1 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 1 | 7 | |
| 76045-006-11 | Morphine Sulfate | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76045-006 | MORPHINE SULFATE (MORPHINE SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ] | 17 | Current NDC, Legacy NDC | 20210310_b62ee1ef-db55-417a-a02e-b103890f9c4b.zip |
| 76045-006 | MORPHINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI, USA LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250412_1f53de80-efc8-4930-b3e3-fba0d026af05.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76045-006-10 | ML - Milliliter | 76045-006 | 6d3d2565-da89-4cd2-9b9d-7a2ef916c481 | 1 | 2014-05-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Morphine Sulfate | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Morphine | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Calcium Chloride | INACTIVE INGREDIENT | M4I0D6VV5M | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Sodium chloride | INACTIVE INGREDIENT | 451W47IQ8X | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Trisodium Citrate Dihydrate | INACTIVE INGREDIENT | B22547B95K | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Baxter Healthcare Corporation | 2a96096d-43cc-49b7-af53-b53c17f41001 | 2014-07-25 | Warnings, Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | Baxter Healthcare Corporation | b3b4b176-41f0-4ca8-90d4-3fba5707564a | 2014-02-21 | 451W47IQ8X | |
| TIS-U-SOL | SODIUM CHLORIDE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, SODIUM PHOSPHATE, AND POTASSIUM PHOSPHATE | Baxter Healthcare Corporation | 9da4121f-d62d-4da4-8dfb-0494da16015f | 2014-02-21 | 451W47IQ8X | |
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X M4I0D6VV5M | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X M4I0D6VV5M |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.